An appeals court has revived a challenge to President Biden's Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
STAT1d
Novo’s new obesity drug shows modest results, raises concerns of psychiatric side effects
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...
Challenge to US drug price negotiation program revived by appeals court
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
Four things you need to know about Medicare drug costs and coverage in 2025
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the ...
Targeted Oncology1d
FDA Clears Investigational New Drug Application for CD-001 in Oncology
Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.
GlobalData on MSN1d
FDA declines approval of Vanda’s gastroparesis treatment
The US Food and Drug Administration (FDA) has declined to approve the new drug application (NDA) submitted by Vanda ...
News Medical2d
New curriculum aims to address substance use disorders in medical education
Nearly 6,000 opioid-related overdose deaths occurred in California in 2021, many due to fentanyl, a synthetic opioid.